MiMedx Group Inc (MDXG) is a Healthcare · Biotechnology company listed on NASDAQ. Price $4.77 (+1.71%), Market cap $0.54B, P/E ratio 18.20, 52-week low–high $3.09 ~ $7.96.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protect
Financial statements, price targets, institutional (13F) holdings and related news for MiMedx Group Inc are updated in real time on BlackAll Trade.
MiMedx Group Inc trades at $4.77 (+1.71%). Real-time quotes and charts are available on BlackAll Trade.
MiMedx Group Inc has a market cap of about $0.54B. Its P/E ratio is 18.20.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placen